North America Healthcare 3D Printing Market size exceeded USD 858.9 million in 2021 and is expected to witness 23.2% CAGR from 2022 to 2028.
Healthcare 3D printing, also known as additive manufacturing, is an additive process whereby 3D objects are developed by using a digital file. 3D printing is used to create living human cells or tissue for use in regenerative medicine and tissue engineering. Also, healthcare 3D printing is used to manufacture precision and personalized pharmaceuticals. The prominent applications of 3D printing include hearing aids, dental devices, contact lenses, and orthopedics implants, among others.
Get more details on this report - Request Free Sample PDF
Increasing R&D investments from manufacturers and institutions in the North America region is expected to boost the market growth. Various applications of 3D printing in healthcare sector and rising demand for personalized medicine in the pharmaceutical industry is set to foster the market size. Medical applications of 3D printing including organ and tissue fabrication, manufacturing of customized implants, prosthetics, anatomical models, 3D printed jawbone, ears, bones, exoskeletons, stem cells, tissues, among others. Also, rising pharmaceutical research regarding drug discovery, dosage forms and delivery owing to increasing R&D investments to develop novel solutions is expected to spur the industry growth.
Furthermore, significant interest is observed from the private and public authorities in the 3D printing marketplace and considerable amounts of funds are granted to manufacturers and universities under various programs for developing innovative solutions.
In North America, the syringe-based segment accounted for 39.9% healthcare 3D printing market share in 2021, attributed to increasing applications of syringe-based products in the field of food printing, bioprinting, and embedded printing. The syringe-based 3D is affordable and readily available that allows rapid prototyping of new ideas in the field of medicine. Also, it can reduce the delay between design and prototype. Furthermore, high flexibility, precision, and ease of controlling the flow rate of material will drive the market revenue.
The North America healthcare 3D printing market from fused deposition modeling (FDM) segment held over USD 362.6 million revenue in 2021, due to widespread applications in healthcare sector that includes tissue engineering, implants, external wearable, and clinical devices. The implants used during surgical procedures are majorly manufactured using FDM technique. Moreover, the fused deposition modeling technology enables to produce functional parts that have complex geometrical shapes in adequate time span. Furthermore, owing to the advantages and cost-effectiveness of fused deposition modeling technology over selective laser sintering technology contributes to the industry size.
The medical application segment will observe around 23% growth rate during the forecast period, owing to increasing medical applications that includes include development of surgical implants that are utilized for patients to recover from the accidents. Also, the use in cell printing and scaffold printing are the leading techniques adopted for the reconstruction of human organs. Furthermore, 3D bioprinting is used to create biological and non-biological research tools in the field of research in broad range of applications.
U.S healthcare 3D printing market size will grow at 24% CAGR, to reach USD 3,672 million by 2028, credited to increasing financial support by the government to improve 3D printing application in the healthcare sector and establishment of research & training centers in the country. For instance, in May 2022, the Government of America, has launched the AM Forward program to drive the growth of additive manufacturing in the country. This program is aimed to support small and medium sized enterprises by the U.S. government and giant multinational companies in several ways to spur the industry outlook.
Some of the notable players in North America healthcare 3D printing market are 3D Biotek, 3D Systems, Aprecia Pharmaceuticals, Digilab, Nano3D Biosciences, TeVido BioDevices, Stratasys, BioBots, among others. These companies implement strategies such as merger, acquisition, partnership, collaborations, business expansion to expend their geographical footprint and strengthen their market position.